KLOW 80MG

RESEARCH COMPOUND

£149.99

KLOW 80MG is a laboratory research containing: • GHK-Cu — 50 mg • BPC-157 — 10 mg • TB-500 — 10 mg • KPV — 10 mg Total peptide content: 80 mg. What is KLOW Protocol? KLOW is a research peptide combination that builds upon the GLOW protocol by adding KPV for enhanced anti-inflammatory effects. This 80mg blend typically contains 50mg GHK-Cu, 10mg TB-500, 10mg BPC-157, and 10mg KPV in a 5:1:1:1 ratio. While individual components have varying levels of research support, no clinical trials have examined this specific four-peptide combination. The protocol remains investigational with theoretical benefits based on complementary mechanisms. Key Benefits Theoretical synergistic effects from four peptides - tissue repair, anti-inflammation, cellular regeneration Supplied exclusively as research material for controlled laboratory and analytical research. The product is not presented as a medicinal product, medical treatment, dietary supplement or therapeutic product. For research use only. Not for human or veterinary use. Not for consumption or administration.

• Supports cellular energy and mitochondrial function (Research Use Only)
• High purity (≥99%) – Third-party tested
• Raw lyophilized powder – Not for human consumption
• For laboratory research purposes only.

For research use only. Not for human consumption.